Efficacy of short novel antimicrobial and anti-inflammatory peptides in a mouse model of methicillin-resistant Staphylococcus aureus (MRSA) skin infection

被引：38
作者：
Mohamed, Mohamed F. [1 ]
Seleem, Mohamed N. [1 ]
机构：
[1] Purdue Univ, Coll Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA
来源：
DRUG DESIGN DEVELOPMENT AND THERAPY | 2014年 / 8卷
关键词：
antimicrobial peptides; MRSA; lysostaphin; skin infection; mice; IN-VIVO; LYSOSTAPHIN; INFLAMMATION; WOUNDS; ALPHA;
D O I：
10.2147/DDDT.S72129
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The therapeutic efficacy of two novel short antimicrobial and anti-inflammatory peptides (RR and RRIKA) was evaluated in a mouse model of staphylococcal skin infection. RR (2%) and RRIKA (2%) significantly reduced the bacterial counts and the levels of proinflammatory cytokines, tumor necrosis factor (TNF)-alpha, and interleukin (IL)-6, in methicillin-resistant Staphylococcus aureus USA 300-0114 skin lesions. Furthermore, the combined therapy of RRIKA (1%) and lysostaphin (0.5%) had significantly higher antistaphylococcal and anti-inflammatory activity compared to monotherapy. This study supports the potential use of these peptides for topical treatment of methicillin-resistant Staphylococcus aureus skin infections.
引用
收藏
页码：1979 / 1983
页数：5
相关论文
共 27 条
[1]   Waves of resistance: Staphylococcus aureus in the antibiotic era [J].
Chambers, Henry F. ;
DeLeo, Frank R. .
NATURE REVIEWS MICROBIOLOGY, 2009, 7 (09) :629-641
[2]   Neutrophil-derived IL-1β Is Sufficient for Abscess Formation in Immunity against Staphylococcus aureus in Mice [J].
Cho, John S. ;
Guo, Yi ;
Ramos, Romela Irene ;
Hebroni, Frank ;
Plaisier, Seema B. ;
Xuan, Caiyun ;
Granick, Jennifer L. ;
Matsushima, Hironori ;
Takashima, Akira ;
Iwakura, Yoichiro ;
Cheung, Ambrose L. ;
Cheng, Genhong ;
Lee, Delphine J. ;
Simon, Scott I. ;
Miller, Lloyd S. .
PLOS PATHOGENS, 2012, 8 (11)
[3]   Noninvasive In Vivo Imaging to Evaluate Immune Responses and Antimicrobial Therapy against Staphylococcus aureus and USA300 MRSA Skin Infections [J].
Cho, John S. ;
Zussman, Jamie ;
Donegan, Niles P. ;
Ramos, Romela Irene ;
Garcia, Nairy C. ;
Uslan, Daniel Z. ;
Iwakura, Yoichiro ;
Simon, Scott I. ;
Cheung, Ambrose L. ;
Modlin, Robert L. ;
Kim, Jenny ;
Miller, Lloyd S. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 (04) :907-915
[4]   IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice [J].
Cho, John S. ;
Pietras, Eric M. ;
Garcia, Nairy C. ;
Ramos, Romela Irene ;
Farzam, David M. ;
Monroe, Holly R. ;
Magorien, Julie E. ;
Blauvelt, Andrew ;
Kolls, Jay K. ;
Cheung, Ambrose L. ;
Cheng, Genhong ;
Modlin, Robert L. ;
Miller, Lloyd S. .
JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (05) :1762-1773
[5]   Etanercept decreases tumor necrosis factor-α activity in chronic wound fluid [J].
Cowin, Allison J. ;
Hatzirodos, Nicholas ;
Rigden, Justin ;
Fitridge, Robert ;
Belford, David A. .
WOUND REPAIR AND REGENERATION, 2006, 14 (04) :421-426
[6]   Topical application of a novel immunomodulatory peptide, RDP58, reduces skin inflammation in the phorbol ester-induced dermatitis model [J].
De Vry, CG ;
Valdez, M ;
Lazarov, M ;
Muhr, E ;
Buelow, R ;
Fong, T ;
Iyer, S .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (03) :473-481
[7]   In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections [J].
Desbois, Andrew P. ;
Gemmell, Curtis G. ;
Coote, Peter J. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 35 (06) :559-565
[8]   Fusidic acid resistance in Staphylococcus aureus [J].
Dobie, D ;
Gray, J .
ARCHIVES OF DISEASE IN CHILDHOOD, 2004, 89 (01) :74-77
[9]   Targeting inflammation in the treatment of type 2 diabetes: time to start [J].
Donath, Marc Y. .
NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (06) :465-476
[10]   Factors Affecting Wound Healing [J].
Guo, S. ;
DiPietro, L. A. .
JOURNAL OF DENTAL RESEARCH, 2010, 89 (03) :219-229
123